received Havrix vaccine after temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 5-year-old patient who received HAV (Havrix) (batch number BM4R5, expiry date APR-2026) for prophylaxis. Additional patient notes included: (redacted) On 21-AUG-2024, the patient received the 1st dose of Havrix (intramuscular, left thigh). On an unknown date, an unknown time after receiving Havrix, the patient experienced incorrect storage of drug (Verbatim: received Havrix vaccine after temperature excursion). The outcome of the incorrect storage of drug was unknown. Additional Information: GSK Receipt Date: 02-DEC-2024 The patient received Havrix vaccine after temperature excursion, which led to an incorrect storage of drug. No adverse event were reported. This was 1 of 17 linked cases, reported by same reporter.; Sender’s Comments: US-GSK-US2024AMR153916:Original Case : US2024AMR153742 US-GSK-US2024AMR153917:Original Case : US2024AMR153742 US-GSK-US2024AMR153918:Original Case : US2024AMR153742 US-GSK-US2024AMR153919:Original Case : US2024AMR153742 US-GSK-US2024AMR153920:Original Case : US2024AMR153742 US-GSK-US2024AMR153921:Original Case : US2024AMR153742 US-GSK-US2024AMR153929:Original Case : US2024AMR153742 US-GSK-US2024AMR153923:Original Case : US2024AMR153742 US-GSK-US2024AMR153924:Original Case : US2024AMR153742 US-GSK-US2024AMR153742:Original Case : US2024AMR153742 US-GSK-US2024AMR153926:Original Case : US2024AMR153742 US-GSK-US2024AMR153927:Original Case : US2024AMR153742 US-GSK-US2024AMR153928:Original Case : US2024AMR153742 US-GSK-US2024AMR153922:Original Case : US2024AMR153742 US-GSK-US2024123268:Same reporter US-GSK-US2024123266:Same reporter